K142282 is an FDA 510(k) clearance for the HUMMINGBIRD(TM) TYMPANOSTOMY TUBE SYSTEM (TTS). Classified as Tube, Tympanostomy (product code ETD), Class II - Special Controls.
Submitted by Preceptis Medical (Plymouth, US). The FDA issued a Cleared decision on April 23, 2015 after a review of 251 days - an extended review cycle.
This device falls under the Ear, Nose, Throat FDA review panel, regulated under 21 CFR 874.3880 - the FDA ear, nose and throat device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ear, Nose, Throat review framework, consistent with the majority of Class II 510(k) submissions.
View all Preceptis Medical devices
NCT02165384
Completed
Interventional
Industry-sponsored
Hummingbird TTS Ear Tube Delivery Study
Continued Evaluation of the Preceptis Medical, Inc. Tympanostomy Ear Tube Introducer
| Condition studied |
Otitis Media |
| Study design |
Single group |
| Eligibility |
All sexes
· 6 Months+
|
| Principal investigator |
Frank Rimell, MD |
| Sponsor |
Preceptis Medical, Inc.
(industry)
|
Started 2014-01-01
→
Primary completion 2018-03-01
Primary outcome
Percentage of Ears in Which an Ear Tube Was Successfully Delivered Across the Tympanic Membrane
View full study on ClinicalTrials.gov